-
This would be a good update for the therapeutics manuscript:
> The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron (REGN.O) an…
-
While the technical infrastructure for data aggregation and integration are sound, we continue to explore use cases that will test whether our knowledge ecosystem is complete enough to answer realisti…
-
Title: Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)
# General Information
## Please paste a link to…
-
Drugs are often given company- or target-specific code names, with a prefix followed by an ID number (for example, AstraZeneca uses the prefix AZD for in-development therapeutics -- their COVID vaccin…
-
Title: A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
## Please paste a link to the paper or a citation here:
Link: https://www.biorxi…
-
https://endpts.com/sangamo-probes-for-fresh-breaches-of-its-digital-security-system-after-top-execs-email-was-hacked/
-
_From @darrenleeweber on May 22, 2016 15:17_
See https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html, no. 20.
- `` was added to `` with the 2010 DTD, but was not used until 2013. e.g.
``…
-
Summary of request: Modify the information in an existing ROR record
Name of organization: Brooklyn ImmunoTherapeutics (United States)
ROR ID: https://ror.org/01gg39979
Which part of the record n…
-
Due to personal exigencies @MedChemProf cannot upload directly and has therefore passed along a data sheet from some months back. It contains a few matched pairs in a metabolic study by Forma Therap…
-
Title: The network effect: studying COVID-19 pathology with the Human Cell Atlas
# General Information
## Please paste a link to the paper or a citation here:
Link: https://doi.org/10.1038/s415…